Coronavirus: What is this treatment that divides scientists? - 20 Minutes
Would the Covid-19 remedy be called chloroquine? This antimalarial molecule, used in the composition of a drug for people suffering from autoimmune diseases, such as rheumatoid arthritis or lupus, could be the solution to fight the coronavirus. But it divides scientists because it would not be without risk.
Derived from chloroquine, hydroxychloroquine, combined with azithromycin, is, according to the team of the controversial professor Didier Raoult, director of the IHU in Marseille, very effective in treating Covid-19. After a first clinical trial carried out on 24 patients in mid-March, a second study carried out by the infectious disease specialist has just been published, this time carried out on 80 patients.
A sale and a prescription now framed
A number still too small to draw conclusions from. Because this new study does not include a control group (patients to whom the study treatment is not administered). It is therefore impossible to make a comparison to determine whether it is the treatment that is causing the improvement in the condition of 80% of the patients observed.
Since the publication of a decree on March 25, to regulate its sale and prescription, only hospital pharmacies are authorized to supply Plaquénil (trade name of hydroxychloroquine) and Kaletra (an antiretroviral combining lopinavir / ritonavir) . And only hospital doctors can prescribe them. Except for initial prescriptions from specialists in rheumatology, internal medicine, dermatology, nephrology, neurology and pediatrics.
Health
Coronavirus: ANSM alert on the treatments tested after three suspicious deaths
Health
Coronavirus: Protocol, risks… The questions raised by Pr Raoult's experiment on chloroquine
- Coronavirus
- Covid 19
- Didier raoult
- Video
- Health